Luwei
Latest round
- Series A
Last raised
- Jan 2026
Total raised
- Undisclosed
Investors
- 1
About Luwei
, Ltd. focuses on creating innovative diagnostic solutions. The company has completed one significant deal as of January 2026. There is no mention of previous pivots or subsidiaries., Ltd. specializes in the research, development, and manufacturing of immunodiagnostic and molecular diagnostic products. The company’s core offerings include the NephroPlex™ assay kit, which utilizes proprietary molecular probe technology to detect polyclonal IgA immune complexes in peripheral blood—an indicator primarily associated with the pathogenesis of IgA nephropathy. This innovative product has been validated as a reliable marker for assessing immune activity in patients with IgA nephropathy, aiding in diagnosis, monitoring, and treatment planning. Additionally, the company addresses cancer recurrence risk assessment through RNA testing, with a notable focus on breast and lung cancers. These diagnostic tools are aimed at healthcare providers, patients, and pharmaceutical companies, facilitating third-party medical testing laboratory services.Shenzhen Luwei Biotechnology generates revenue through the sale of diagnostic products and services, structured primarily as B2B transactions with healthcare institutions, laboratories, and pharmaceutical companies. The firm’s flagship NephroPlex™ assay kit and other RNA testing services for breast and lung cancer are offered directly to clinical labs and hospitals, which may implement these diagnostics in their treatment protocols. Revenue transactions generally involve the purchase of testing kits, which are priced based on their specific diagnostic capabilities and associated services. Additionally, partnerships with healthcare providers may facilitate bulk purchases and long-term contracts, enhancing the firm's revenue streams.
Who invested in Luwei
1 investor across 1 round
See all investors in Luwei
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Jan 23, 2026
Amount
Undisclosed
Investors
Questions about Luwei
Who invested in Luwei?
Luwei has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Luwei raised?
Luwei has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Luwei last raise money?
Luwei's most recent round on record is a Series A, in Jan 2026.
What does Luwei do?
Luwei is a biotechnology company.
Where is Luwei headquartered?
Luwei is headquartered in Shenzhen, China.
Which VCs invest in companies like Luwei?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Luwei's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Luwei? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.